Literature DB >> 14622714

Report of three case studies with olanzapine for chronic pain.

Eugene D Gorski1, Kerry C Willis.   

Abstract

Olanzapine, an atypical antipsychotic, has broad spectrum psychotropic effects, affecting dopamine receptors 1, 2, and 3, 5-hydroxytryptamine 2A, 5-hydroxytryptamine 2C, muscarinic, alpha-adrenergic, alpha-adrenergic, and histamine H-sites. This unique pharmacologic property allows clinicians to use the agent as an adjunct for pain control, particularly when the intensity of the pain is exacerbated by dysregulation of neurotransmitters. Three case studies are presented from a suburban family practice setting in which olanzapine has been successfully used to regulate pain perception in adults with chronic pain.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14622714     DOI: 10.1054/jpai.2003.438

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  4 in total

1.  [Cenesthesia as a rare differential diagnosis of persistent idiopathic facial pain].

Authors:  J Steiner; B Bogerts; D Hoffmeyer; M Brinkers
Journal:  Nervenarzt       Date:  2007-02       Impact factor: 1.214

2.  Olanzapine Attenuates Mechanical Allodynia in a Rat Model of Partial Sciatic Nerve Ligation.

Authors:  Taeko Fukuda; Soichiro Yamashita; Setsuji Hisano; Makoto Tanaka
Journal:  Korean J Pain       Date:  2015-07-01

Review 3.  Advances in diagnostic and treatment options in patients with fibromyalgia syndrome.

Authors:  Ali Gur; Pelin Oktayoglu
Journal:  Open Access Rheumatol       Date:  2009-12-09

Review 4.  The Benefits of Olanzapine in Palliating Symptoms.

Authors:  Mellar P Davis; Gareth J Sanger
Journal:  Curr Treat Options Oncol       Date:  2020-11-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.